Fresenius Medical Care AG & Co. KGaA announced that at its Annual General Meeting a large shareholder majority of 88.27% approved a 10% increase in the dividend, from EUR 0.96 to EUR 1.06, the company's 21st consecutive dividend increase. Shareholder majorities of 99.23% and 95.46%, respectively, approved the actions of the Management and Supervisory Boards in 2017.

Dr. Gerd Krick, Chairman of the Supervisory Board of Fresenius Medical Care AG & Co. KGaA, announced that he will resign from the Supervisory Board, effective at the meeting's end. He will maintain his position on the Supervisory Board of the General Partner, Fresenius Medical Care Management AG.Dr. Krick had been Chief Executive Officer of Fresenius Medical Care from 1996, when the company was founded, to 1998, laying the foundation for its global success. In 1998, he resigned from his CEO position and became Chairman of the Supervisory Board of Fresenius Medical Care. The Supervisory Board has appointed Dr. Dieter Schenk, Vice Chairman of the Supervisory Board of Fresenius Medical Care AG & Co. KGaA, as the new Chairman. A new member of the Supervisory Board will be appointed in due course and proposed for election at the next Annual General Meeting, which is expected to take place on May 16, 2019.